Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mucus secretion in the airway tract is a complex physiological process crucial for maintaining respiratory health. It involves the production and secretion of mucins, primarily MUC5AC and MUC5B, by goblet cells, club cells, and submucosal glands. This secretion traps inhaled particles and pathogens, facilitating their removal via mucociliary clearance and cough. Dysregulation of mucus secretion, leading to hypersecretion or altered mucus properties, contributes to the pathophysiology of various respiratory diseases, including asthma, COPD, and cystic fibrosis. The expectorant effect encompasses mechanisms and agents that enhance mucus secretion or its clearance from the airways, often targeted therapeutically.
Expectorants: Increase airway hydration and mucus volume. Mucolytics: Break down mucus structure to reduce viscosity. Bronchodilators: Relax airway smooth muscle, facilitating mucus clearance. Corticosteroids: Reduce airway inflammation and mucus production. Macrolides: Reduce mucus hypersecretion and inflammation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucus Secretion in the Airway Tract (N/A).